ArticleBMJ open2022

Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study.

Jessica M Heijdra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.